Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Gelesis Holdings, Inc. Gelesis’ Oral Treatment for Weight Management Showed Real-World Effectiveness in New Data Presented at the American Diabetes Association’s Annual Conference June 26, 2023 From Gelesis Holdings, Inc. Via Business Wire Gelesis Reports Fourth Quarter and Full Year 2022 Results March 28, 2023 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Gelesis to Participate in the 25th Annual ICR Conference January 05, 2023 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Gelesis Reports Upcoming Participation in Wolfe Research’s Annual Consumer Growth Conference November 21, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Gelesis Receives Notice of NYSE Market Capitalization Listing Rule Non-Compliance November 18, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Gelesis Reports Third Quarter 2022 Results November 14, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Gelesis to Report Third Quarter 2022 Financial Results on November 14, 2022 November 07, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Gelesis Receives Notice of NYSE Trading Share Price Listing Rule Non-Compliance November 04, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Data Presented at Obesity Week Demonstrate that Gelesis Investigational Clinical-Stage Oral Superabsorbent Hydrogel Gel-B Preferentially Enhances the Growth of Akkermansia muciniphila in Preclinical Models Compared to Prebiotics November 02, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Dr. Frank Greenway to Present Data from the LIGHT-UP Study with Gelesis’ Oral Hydrogel Treatment GS200 at Obesity Week November 01, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Clinical Data from the LIGHT-UP Study Presented at the International Congress of Endocrinology Suggests New Gelesis Oral Hydrogel May Improve Insulin Sensitivity and Favorably Impact Metabolic Syndrome August 25, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Gelesis Reports Second Quarter 2022 Results August 15, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Gelesis to Report Second Quarter 2022 Financial Results on August 15, 2022 August 04, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Gelesis Announces Additional $15 Million Pre-Order for Plenity®, Bringing Total Pre-Paid Orders from Ro for Plenity to $55 Million June 21, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Over the Past Decade, Person-First Language Was Used in Only About Half of Diabetes-Focused Articles and Fewer than 1% of Obesity Articles, Finds New Study June 05, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Microbiota Transplantation Demonstrates How Gut Bacteria Contributes to Weight Loss and Beneficial Metabolic Effects with Gelesis’ Proprietary Hydrogel June 04, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Gelesis to Participate in Upcoming Investor Conferences May 18, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Gelesis Reports First Quarter 2022 Results May 12, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Gelesis to Report First Quarter 2022 Financial Results on May 12, 2022 May 09, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Clinical Data Presented at the European Congress on Obesity 2022 Demonstrates Weight Loss With GS200 in Adults With Prediabetes and Type 2 Diabetes May 04, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Gelesis’ Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New Study April 29, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Gelesis® Reports Fiscal Year 2021 Results and Fiscal Year 2022 Financial Outlook March 24, 2022 From Gelesis Holdings, Inc. Via Business Wire Tickers GLS Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.